These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34335761)

  • 21. A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery.
    Mao Q; Xia W; Dong G; Chen S; Wang A; Jin G; Jiang F; Xu L
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1784-1792.e3. PubMed ID: 29554790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival Following Segmentectomy or Lobectomy in Patients With Stage IB Non-small-cell Lung Cancer.
    Hao B; Zhang L; Fan T; Liu B; Jiang W; Hu H; Geng Q
    Front Oncol; 2020; 10():661. PubMed ID: 32500023
    [No Abstract]   [Full Text] [Related]  

  • 23. Prognostic value of visceral pleural invasion in the stage pT
    Zhang X; Xie J; Hu S; Peng W; Xu B; Li Y; Li C
    Curr Probl Cancer; 2021 Feb; 45(1):100640. PubMed ID: 32828574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of adjuvant chemotherapy on patients with stage IB non-small cell lung cancer with visceral pleural invasion.
    Kim BG; Choi J; Lee SK; Choi SI; Park CK; Sim JK; Lee H; Kim SH; Sohn JW; Yoon HJ; Lee SY; Park DW
    J Thorac Dis; 2024 Feb; 16(2):875-883. PubMed ID: 38505035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nomogram for the prediction of lymph node metastasis and survival outcomes in rectal neuroendocrine tumour patients undergoing resection.
    Chen Q; Chen J; Deng Y; Zhang Y; Huang Z; Zhao H; Cai J
    J Gastrointest Oncol; 2022 Feb; 13(1):171-184. PubMed ID: 35284104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
    Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of a prognostic predictive model of pulmonary spindle cell carcinoma from the surveillance, epidemiology and end results database.
    Li W; Zhang M; Fu S; Hao X; Song L; Wang J; Liu B; Xu S
    Transl Cancer Res; 2022 Aug; 11(8):2783-2794. PubMed ID: 36093529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefit of adjuvant chemotherapy for patients with stage IB non-small cell lung cancer: a systematic review and meta-analysis.
    Wang X; Chen D; Wen J; Mao Y; Zhu X; Fan M; Chen Y
    Ann Transl Med; 2021 Sep; 9(18):1430. PubMed ID: 34733982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.
    Li H; Wang Z; Yang F; Wang J
    J Surg Oncol; 2020 May; 121(6):1027-1035. PubMed ID: 32026478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A SEER population analysis of stage IB resected gastric cancer: who can benefit from adjuvant therapy?
    Wang Y; Guo S; Zhang J; Meng XY; Zheng ZC; Zhao Y
    Scand J Gastroenterol; 2020 Feb; 55(2):193-201. PubMed ID: 31976783
    [No Abstract]   [Full Text] [Related]  

  • 31. Nomograms for Predicting Overall and Recurrence-free Survival From Pathologic Stage IA and IB Lung Cancer After Lobectomy.
    Merritt RE; Abdel-Rasoul M; Fitzgerald M; D'Souza DM; Kneuertz PJ
    Clin Lung Cancer; 2021 Jul; 22(4):e574-e583. PubMed ID: 33234491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of overall survival of non-small cell lung cancer with bone metastasis: an analysis of the Surveillance, Epidemiology and End Results (SEER) database.
    Shi S; Wang H; Liu X; Xiao J
    Transl Cancer Res; 2021 Dec; 10(12):5191-5203. PubMed ID: 35116369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A nomogram for the prediction of overall survival in patients with stage II and III non-small cell lung cancer using a population-based study.
    Liao Y; Wang X; Zhong P; Yin G; Fan X; Huang C
    Oncol Lett; 2019 Dec; 18(6):5905-5916. PubMed ID: 31788064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma.
    Liang Z; Zhang E; Duan L; Weygant N; An G; Hu B; Yao J
    Technol Cancer Res Treat; 2022; 21():15330338211068960. PubMed ID: 35179409
    [No Abstract]   [Full Text] [Related]  

  • 35. The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy.
    Yang H; Wang K; Li S; Li Y; Yuan L
    Pathol Oncol Res; 2021; 27():1609898. PubMed ID: 34447289
    [No Abstract]   [Full Text] [Related]  

  • 36. A nomogram for predicting overall survival in patients with resected non-small cell lung cancer treated with chemotherapy.
    Zeng Y; Mayne N; Yang CJ; Liu J; Cui F; Li J; Liang W; He J;
    Transl Lung Cancer Res; 2021 Apr; 10(4):1690-1699. PubMed ID: 34012785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nomogram for predicting prognosis and identifying chemotherapy beneficiaries for completely resected stage I invasive mucinous lung adenocarcinoma.
    He H; Zeng X; Zhang Q; Hu W; Huang R; Zhao H; Sun S; Lin R; Yue P; Han B; Ma M; Chen C
    Transl Lung Cancer Res; 2024 Jan; 13(1):95-111. PubMed ID: 38404999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Valuable Prognostic Impact of Regional Lymph Node Removed on Outcomes for IIIA N0 NSCLC Patients.
    Wang Y; Liu Z; Zhou Z; Rao H; Xiong J; Xie S
    J Cancer; 2023; 14(11):2093-2108. PubMed ID: 37497411
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of surgery for atypical bronchopulmonary carcinoid tumor: Development and validation of a model based on Surveillance, Epidemiology, and End Results (SEER) database.
    Chen X; Pang Z; Wang Y; Bie F; Zeng Y; Wang G; Du J
    Lung Cancer; 2020 Jan; 139():94-102. PubMed ID: 31759223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment and Validation of a Nomogram Based on Negative Lymph Nodes to Predict Survival in Postoperative Patients with non-Small Cell Lung Cancer.
    Huang X; Hu P; Yan F; Zhang J
    Technol Cancer Res Treat; 2022; 21():15330338221074506. PubMed ID: 35060800
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.